Physician profile
David Tuke
NPI 1053725077
$7,397.89
in general payments reported to CMS, 2019-2025
29 companies · $71.48 in 2025
The $71.48 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $360 · 2021: $1,635 · 2022: $2,883 · 2023: $1,705 · 2024: $446 · 2025: $71.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,782.95 | 2020-2024 | Greenlight Xps |
| Sun Pharmaceutical Industries INC. | $438.42 | 2023 | Yonsa |
| Baxter Healthcare | $400.88 | 2020-2023 | Tisseel |
| Medical Device Business Services, INC. | $400.73 | 2021 | |
| Ethicon US, LLC | $373.89 | 2021-2023 | Enseal, Echelon Flex, Ethicon |
| Coloplast Corp | $346.78 | 2021-2024 | Altis |
| Endo Pharmaceuticals INC. | $281.30 | 2021-2023 | Xiaflex, Aveed |
| Innovation Technologies INC | $250.00 | 2023 | Irrisept |
| Medtronic, INC. | $236.37 | 2021-2024 | Aquamantys(Tm) |
| Genzyme Corporation | $236.20 | 2020-2021 | |
| Teleflex LLC | $236.15 | 2023-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $182.26 | 2019-2022 | |
| Cook Medical LLC | $181.99 | 2021-2024 | Ncircle, Cook |
| Stryker Corporation | $159.96 | 2020-2023 | Iris |
| Axonics, INC. | $140.35 | 2022-2023 | Axonics |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $138.45 | 2021 | |
| Pfizer INC. | $117.98 | 2019 | |
| Abbvie INC. | $115.19 | 2020-2022 | |
| Progenics Pharmaceuticals, INC. | $104.37 | 2022 | |
| Hollister Incorporated | $50.73 | 2021 | |
| Ambu INC. | $48.29 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.18 | 2019-2021 | |
| 180 Medical, INC. | $27.79 | 2021 | |
| Urogen Pharma, INC. | $24.22 | 2022 | |
| Acell, INC. | $21.48 | 2019 | |
| Myovant Sciences INC. | $20.40 | 2021 | |
| Tolmar, INC. | $19.06 | 2023 | |
| Convatec INC. | $15.33 | 2021 | |
| Endo USA, INC. | $15.19 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tuke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.